Comments
Loading...
Genex Pharmaceutical Analyst Ratings and Price Targets | OTC:GENX | Benzinga
Genex Pharmaceutical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Genex Pharmaceutical Corp from these most-recent analyst ratings.
Analyst Ratings for Genex Pharmaceutical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Genex Pharmaceutical (GENX) stock?
There is no price target for Genex Pharmaceutical
What is the most recent analyst rating for Genex Pharmaceutical (GENX)?
There is no analyst for Genex Pharmaceutical
When was the last upgrade for Genex Pharmaceutical (GENX)?
There is no last upgrade for Genex Pharmaceutical
When was the last downgrade for Genex Pharmaceutical (GENX)?
There is no last downgrade for Genex Pharmaceutical.
When is the next analyst rating going to be posted or updated for Genex Pharmaceutical (GENX)?
There is no next analyst rating for Genex Pharmaceutical.
Is the Analyst Rating Genex Pharmaceutical (GENX) correct?
There is no next analyst rating for Genex Pharmaceutical.
Browse analyst ratings and price targets on all stocks.